PedAM
Pediatric Disease Annotations & Medicines
| Disease | hematopoietic stem cell transplantation |
| Phenotype | C0023470|myeloid leukemia |
| Sentences | 17 |
| PubMedID- 21362241 | [preliminary analysis of therapeutic efficacy and prognosis of allogeneic hematopoietic stem cell transplantation in patients with advanced chronic myeloid leukemia]. |
| PubMedID- 24417923 | [treatment efficacy of imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in chronic phase]. |
| PubMedID- 24767158 | [clinical outcome of flt3-itd (+) acute myeloid leukemia patients treated with allogeneic hematopoietic stem cell transplantation]. |
| PubMedID- 25550955 | Reduced-intensity and myeloablative conditioning allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome: a meta-analysis and systematic review. |
| PubMedID- 20305143 | Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia. |
| PubMedID- 23728608 | Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia. |
| PubMedID- 25072307 | Comparison of reduced-intensity and myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and acute lymphoblastic leukemia: a meta-analysis. |
| PubMedID- 24060407 | Comparison of unrelated cord blood transplantation and hla-matched sibling hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in advanced stage. |
| PubMedID- 26422713 | Cd25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplantation predicts relapse in patients with acute myeloid leukemia without complete remission. |
| PubMedID- 23396805 | Allogeneic nk cells exhibit potent anti-tumor activities that are beneficial in the setting of hematopoietic stem cell transplantation into patients with acute myeloid leukemia (9). |
| PubMedID- 25380682 | Contribution of non-infectious transplantation-related complications to the outcome of hematopoietic stem cell transplantation in patients with acute myeloid leukemia: a single institute analysis. |
| PubMedID- 26230954 | Leukemia relapse remains the top cause of death post allogeneic hematopoietic stem cell transplantation (allosct) in patients with acute myeloid leukemia (aml).1 once leukemia relapse occurs, the prognosis is generally poor with the overall 5-year survival of only 5% and medium time to death of 3–4 months.2, 3 treatment options in this population are extremely limited. |
| PubMedID- 23341720 | Growth after hematopoietic stem cell transplantation in children with acute myeloid leukemia. |
| PubMedID- 22783362 | Chronic graft versus host disease with small bowel obstruction after unrelated hematopoietic stem cell transplantation in a patient with acute myeloid leukemia. |
| PubMedID- 21421478 | Objective: to analyze the influence of hla compatibility on the outcome of allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with chronic myeloid leukemia (cml). |
| PubMedID- 25687068 | [analysis of prognosis in acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation]. |
| PubMedID- 26183077 | Chimerism testing after allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with acute myeloid leukemia (aml) and myelodysplastic syndromes (mds) represents a promising tool for predicting disease relapse, although its precise role in this setting remains unclear. |
Page: 1